bioMérieux S.A.

bioMérieux S.A.

BIM · Euronext Paris

bioMérieux S.A. (BIM) is a Medical diagnostics research company in the Healthcare sector, listed on Euronext Paris. This page provides the complete earnings calendar, dividend schedule, and financial data for bioMérieux S.A. in 2026. The next earnings report is expected on March 4, 2027.

Earnings calendar

Next earnings date

04 Mar 2027

In 195 days

EPS estimate

2.92

Revenue estimate

2.5B

Past earnings

28 Jul 2026
EPS actual
2.27 (-2.0%)
estimate 2.32
Revenue actual
2.2B (+1.5%)
estimate 2.2B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

bioMérieux S.A. missed consensus estimates on EPS but beat on revenue, with EPS of USD 2.2727 falling 2.0% short of expectations versus an estimate of USD 2.3184 and revenue of USD 2.24 billion exceeding estimates by 1.5% versus an estimate of USD 2.21 billion. There is no previous report available for comparison.

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Past dividends

Ex-dividend Payment Amount
09 Jun 2026 11 Jun 2026 1.13

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.

Sector
Healthcare
Industry
Medical diagnostics research
Country
France
Exchange
Euronext Paris
CEO
Pierre Boulud
Employees
14,894
IPO date
07 Jul 2004
ISIN
FR0013280286
Website
biomerieux.com

Frequently asked questions

When does bioMérieux S.A. (BIM) next report earnings?

bioMérieux S.A. (BIM) is scheduled to report earnings on March 4, 2027.

What was bioMérieux S.A.'s most recent earnings date?

bioMérieux S.A. (BIM) last reported earnings on July 28, 2026.

Where is bioMérieux S.A. stock listed?

bioMérieux S.A. (BIM) is listed on Euronext Paris.